PCOS (polycystic ovary syndrome) is the most common hormonal disorder in women of reproductive age; according to the Rotterdam criteria, it combines at least two of the following three features: irregular cycles, an excess of androgen hormones, and a particular appearance of the ovaries on ultrasound or a raised AMH. It is a common cause of difficulty conceiving, but ovulation treatments are effective: in a trial published in the New England Journal of Medicine, 27.5% of women treated with letrozole had a live birth, compared with 19.1% on clomifene. PCOS also carries a metabolic risk (diabetes, cholesterol, weight) that justifies long-term follow-up.
PCOS is a hormonal imbalance that affects how the ovaries work. The ovaries contain many small follicles (the "cysts" in the name, which are not really cysts) that start to develop but do not reach maturity. Ovulation becomes irregular, or even absent.
Two mechanisms reinforce each other:
There is a family component. Being overweight does not cause PCOS, but it often makes its manifestations worse.
The signs vary greatly from one woman to another.
In adults, the diagnosis is based on the presence of at least two of the following three criteria, after other causes have been ruled out (thyroid disease, excess prolactin, congenital adrenal hyperplasia, secreting tumour).
| Criterion | How it is assessed |
|---|---|
| 1. Ovulation disorders | Questions about the length and regularity of cycles |
| 2. Hyperandrogenism | Clinical (hirsutism, acne, alopecia) or biochemical (testosterone measurement) |
| 3. Polycystic ovarian morphology or raised AMH | Transvaginal ultrasound: increased number of follicles or ovarian volume; or measurement of anti-Müllerian hormone (AMH) in adults |
The international guideline coordinated by Teede, published in 2023 and supported in particular by ESHRE (European Society of Human Reproduction and Embryology), brings several clarifications:
Pelvic ultrasound is performed at the practice, including 3D ultrasound if needed. To find out more about this examination: "Pelvic ultrasound in gynaecology: technique and indications".
No. In PCOS, AMH is often high because the ovaries contain many small follicles. This reflects an abundant ovarian reserve, but does not guarantee regular ovulation. See "Ovarian reserve: definition, assessment (AMH, AFC) and impact on fertility".
No. PCOS is a common cause of infertility due to lack of ovulation, but most women affected can conceive, either spontaneously or with treatment. The main difficulty concerns ovulation.
The fertility work-up also checks the fallopian tubes and the partner’s sperm, as for any couple. See "Couple infertility: which tests after a year of trying without pregnancy?".
The 2023 guideline emphasises effective, safe and inexpensive treatments, given in steps.
| Step | Treatment | Key points |
|---|---|---|
| 1 | Lifestyle measures | Regular physical activity, balanced diet; moderate weight loss in women who are overweight may be enough to restore ovulation |
| 2 | Letrozole (first line) | Tablet at the start of the cycle to induce ovulation; ultrasound monitoring |
| 2a | Clomifene, possibly combined with metformin | Alternative if letrozole is not used |
| 3 | Gonadotrophins (injections) or laparoscopic ovarian drilling | If tablets fail; close monitoring to limit the risk of multiple pregnancy |
| 4 | In vitro fertilisation | If the previous steps fail or if there is another infertility factor |
The randomised trial by Legro, published in 2014 in the New England Journal of Medicine, compared letrozole and clomifene in 750 women with PCOS. The cumulative live birth rate was 27.5% with letrozole versus 19.1% with clomifene, with a higher ovulation rate and no significant difference in malformations. These results led the international guideline to recommend letrozole as first-line treatment.
In France, the use of letrozole for this indication is an off-label prescription (outside its marketing authorisation); your doctor will inform you of this.
Women with PCOS often respond strongly to stimulation. The main risk is ovarian hyperstimulation syndrome, which is prevented by adapted protocols and, if needed, freezing all the embryos. See "In vitro fertilisation (IVF): procedure, stages and treatment". If needed, Dr Kadoch refers you to an assisted reproduction centre.
Why bring on periods? When ovulation is absent for a long time, the endometrium is exposed to oestrogens without the protective effect of progesterone, which in the long term increases the risk of abnormal thickening (hyperplasia) of the endometrium.
The 2023 guideline reinforces the recognition of PCOS as a whole-body disorder, not just a gynaecological one.
| Risk | Suggested monitoring |
|---|---|
| Type 2 diabetes and glucose intolerance | Oral glucose tolerance test (the most reliable test), or otherwise fasting blood glucose or HbA1c, every 1 to 3 years depending on risk factors |
| High cholesterol, high blood pressure | Lipid profile, blood pressure measurement |
| Cardiovascular disease | Management of risk factors |
| Sleep apnoea | Screening for snoring and daytime sleepiness |
| Pregnancy complications (gestational diabetes, high blood pressure, premature birth) | Early screening for gestational diabetes, careful follow-up |
| Anxiety, depression, eating disorders | Systematic screening, referral if needed |
| Endometrial hyperplasia | Regular periods, investigate any abnormal bleeding |
Cycles tend to become more regular with age, and hyperandrogenism often lessens. However, the metabolic risk persists, hence the value of continuing regular medical follow-up.
Would you like a medical opinion?Appointments in Paris 16th or 5th, or by video consultation.
Book an appointmentNo. A multifollicular appearance of the ovaries is common in women without PCOS, especially young women. The diagnosis requires at least two of the three criteria and the exclusion of other causes.
The pill regulates cycles and reduces androgen-related signs for as long as it is taken. To make the diagnosis, the doctor relies on the history of cycles before the pill or sometimes suggests repeating tests after stopping it.
If you are overweight, even moderate weight loss often improves ovulation. But ovulation treatment is not reserved for women of normal weight and should not be postponed indefinitely, especially after 35.
The data are debated. However, a pregnancy in a woman with PCOS is considered at risk of gestational diabetes and high blood pressure, which justifies appropriate follow-up. See "Antenatal care in France: appointments, scans and tests month by month".
There is a family predisposition, but it is not systematic. In adolescents, the diagnosis is not based on ultrasound and must be made with caution.
A question about your situation?Appointments at the practice or by video consultation, usually within one week to 10 days.
Book an appointmentGeneral information article: it does not replace a medical consultation. In an emergency, call 15 or 112 in France, or your local emergency number.